Y020-2199 Screening compound: 1-(4-fluorophenyl)-3-[(2-methoxyphenyl)amino]-4,5,6,7-tetrahydro-1H-indazol-4-one

Y020-2199 Screening compound: 1-(4-fluorophenyl)-3-[(2-methoxyphenyl)amino]-4,5,6,7-tetrahydro-1H-indazol-4-one
Y020-2199 Screening compound: 1-(4-fluorophenyl)-3-[(2-methoxyphenyl)amino]-4,5,6,7-tetrahydro-1H-indazol-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-2199
1-(4-fluorophenyl)-3-[(2-methoxyphenyl)amino]-4,5,6,7-tetrahydro-1H-indazol-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-2199

Molecular Formula

C20H18FN3O2 (C20 H18 FN3 O2)

Compound Name

1-(4-fluorophenyl)-3-[(2-methoxyphenyl)amino]-4,5,6,7-tetrahydro-1H-indazol-4-one

IUPAC name

1-(4-fluorophenyl)-3-[(2-methoxyphenyl)amino]-4567-tetrahydro-1H-indazol-4-one

SMILES

COc(cccc1)c1Nc(c1c2CCCC1=O)nn2-c(cc1)ccc1F

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

351.38

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.141

Distribution Coefficient, logD

4.141

Water Solubility, LogSw

-4.55

Polar Surface Area

43.718

Acid Dissociation Constant (pKa)

15.44

Base Dissociation Constant (pKb)

-0.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

Y020-2199 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • Epigenetic
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with Y020-2199 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-2199?
Check Price and Availability of Y020-2199, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-2199 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-2199
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-2199
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-2199 available by request